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Cholinesterase inhibitors have beneficial effects on cognitive, functional, and behavioural symptoms of 
Alzheimer’s disease (AD). Up to date, they represent the only drugs approved by U.S: Food and Drug 
Administration for AD treatment. These include donepezil, rivastigmine and galantamine. Apart from the 
above mentioned cholinesterase inhibitors memantine is used for AD treatment as well, acting as N methyl-
D-aspartate antagonist drug. 
Tacrine (9-amino-1,2,3,4-tetrahydroacridine) was the first cholinesterase inhibitor to obtain a marketing 
authorisation in symptomatic treatment of AD. However, its several side effects (hepatotoxicity and 
gastrointestinal discomfort) limited tacrine broader usage. Novel tacrine derivatives are extensively 
investigated in endeavour to find less toxic compounds with „multi-target directed ligand“ profile affecting 
more pathological mechanisms. 
As a part of these research efforts, 7-methoxytacrine (7-MEOTA) has been prepared as a less toxic derivate 
compared to tacrine with the same pharmacological profile. 
Within this doctoral thesis, novel derivatives of tacrine and 7-MEOTA were synthesized, biologically 
evaluated for their cholinergic potential towards both cholinesterases – acetylcholinesterase (AChE, E.C. 
3.1.1.7) and butyrylcholinesterase (BChE; E.C. 3.1.1.8). To rationalize findings from in vitro assay, the 
plausible orientation of the most perspective compounds in the active site of cholinesterases were computed 
and visualized. 
Besides biological data and molecular modelling studies, the structure-activity relationships are also 
discussed. For the most promising analogues in the series of urea/thiourea derived from tacrine 7 MEOTA 
conjugates, we deal with in vivo toxicity assessments on animals, monoaminooxidase and NADH 
dehydrogenase activity as well as with determination of anti-amyloid activities (tested on insulin, lysozyme 
and Aβ1-40).  
